You have 9 free searches left this month | for more free features.

ibi376

Showing 1 - 2 of 2

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Inert Non Hodgkin's Lymphoma Trial in Beijing (IBI376, Rituximab)

Recruiting
  • Inert Non Hodgkin's Lymphoma
  • IBI376
  • Rituximab
  • Beijing, China
    Biotherapeutic Department, Chinese PLA General Hospital
Feb 19, 2022

Indolent Non-hodgkin Lymphoma Trial in Shanghai (IBI376)

Recruiting
  • Indolent Non-hodgkin Lymphoma
  • IBI376
  • Shanghai, China
    Ruijin hospital, school of medicine, Shanghai jiao tong universi
May 26, 2020